Intelligent Bio Solutions INBS
NASDAQ INBS
$1.63 -0.02 (-1.21%)
As of: Sep 29, 2026 · 3:59 PM EDT

Intelligent Bio Solutions (INBS) Current Leases (2022 - 2023)

Updated

Intelligent Bio Solutions (INBS) posted Current Leases of $174,215 for fiscal Q3 2023 (quarter ended Mar 31, 2023), up 8.3% from the prior quarter.

Analysis

Intelligent Bio Solutions (INBS) Current Leases (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn -
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn -
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn -
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn -
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn -
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn -
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn -
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn -
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn -
10 Intelligent Bio Solutions 2.43 Mn -11.04 Mn 536,583.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 174,215.00
Dec 31, 2022 160,826.00
API Access

Intelligent Bio Solutions Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=INBS&period=max&api_key=YOUR_API_KEY